Finance

Beta
Lists
UG2:FRA
AngioDynamics, Inc.
€10.40
+0.97%
(+0.100) 1D
Jun 12, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for UG2...
Open
€10.40
High
€10.40
Low
€10.40
Mkt. cap
499.96M
Avg. vol.
4.00
Volume
0.00
52-wk high
€13.20
52-wk low
€7.00
No. of employees
675
Open
€10.40
High
€10.40
Low
€10.40
Mkt. cap
499.96M
Avg. vol.
4.00
Volume
0.00
52-wk high
€13.20
52-wk low
€7.00
No. of employees
675
News stories
From sources across the web
About AngioDynamics, Inc.
CEOJames Clemmer
Employees675
FoundedFeb 9, 1988
Headquarters-
SectorMedical device
Websiteangiodynamics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
80.16M
75.71M
79.43M
78.42M
Cost of goods sold
37.94M
33.85M
34.65M
36.94M
Cost of revenue
37.94M
33.85M
34.65M
36.94M
Research and development expenses
6.50M
6.32M
7.63M
6.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.76M
40.78M
37.00M
38.31M
Operating expense
45.85M
49.76M
47.27M
47.91M
Total operating expenses
83.79M
83.61M
81.92M
84.85M
Operating income
-3.63M
-7.90M
-2.49M
-6.43M
Other non operating income
-325.00K
-178.00K
-128.00K
4.97M
EBT including unusual items
-6.11M
-10.84M
-6.36M
-8.07M
EBT excluding unusual items
-3.96M
-8.08M
-2.72M
-1.55M
Income tax expense
-60.00K
65.00K
-5.00K
12.00K
Effective tax rate
0.98%
-0.60%
0.08%
-0.15%
Other operating expenses
-
-
-
-
Net income
-6.05M
-10.90M
-6.35M
-8.08M
Net profit margin
-7.55%
-14.40%
-7.99%
-10.31%
Earnings per share
-0.03
-0.10
-
0.02
Interest and investment income
100.00K
-
-
12.00K
Interest expense
-97.00K
-4.00K
-102.00K
-100.00K
Net interest expenses
3.00K
-4.00K
-102.00K
-88.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.20M
-1.88M
3.26M
-838.00K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer